Free Trial
OTCMKTS:BICX

BioCorRx (BICX) Stock Price, News & Analysis

BioCorRx logo
$0.35 +0.04 (+11.39%)
(As of 05:36 PM ET)

About BioCorRx Stock (OTCMKTS:BICX)

Key Stats

Today's Range
$0.31
$0.35
50-Day Range
$0.30
$0.50
52-Week Range
$0.28
$1.50
Volume
1,151 shs
Average Volume
1,945 shs
Market Capitalization
$4.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Receive BICX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioCorRx and its competitors with MarketBeat's FREE daily newsletter.

BICX Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
BioCorRx Inc. (BICX)
See More Headlines

BICX Stock Analysis - Frequently Asked Questions

BioCorRx's stock was trading at $0.78 on January 1st, 2024. Since then, BICX stock has decreased by 55.7% and is now trading at $0.3453.
View the best growth stocks for 2024 here
.

BioCorRx Inc. (OTCMKTS:BICX) posted its earnings results on Thursday, November, 17th. The company reported ($0.02) earnings per share for the quarter. The firm had revenue of $0.17 million for the quarter.

Shares of BICX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioCorRx investors own include PlayAGS (AGS), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Mondi (MNDI), Assertio (ASRT), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

Last Earnings
11/17/2016
Today
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:BICX
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-3,770,000.00
Net Margins
-11,600.00%
Pretax Margin
-11,637.84%

Debt

Sales & Book Value

Annual Sales
$90,000.00
Book Value
($1.14) per share

Miscellaneous

Free Float
9,828,000
Market Cap
$4.32 million
Optionable
Not Optionable
Beta
0.61

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:BICX) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners